Guaifenesin (Glyceryl Guaiacolate)

A to Z Drug Facts

Guaifenesin (Glyceryl Guaiacolate)

  Action
  Indications
  Contraindications
  Route/Dosage
  Interactions
  Lab Test Interferences
  Adverse Reactions
  Precautions
Patient Care Considerations
  Administration/Storage
  Assessment/Interventions
  Patient/Family Education


(GWHY-fen-ah-sin)
Anti-Tuss
Syrup
100 mg/5 mL
Breonesin
Capsules
200 mg
Diabetic Tussin EX
Liquid
100 mg/5 mL
Duratuss-G
Tablets
1200 mg
Fenesin
Tablets, sustained release
600 mg
Gee-Gee
Tablets
200 mg
Genatuss
Syrup
100 mg/5 mL
GG-Cen
Capsules
200 mg
Glyate
Syrup
100 mg/5 mL
Glycotuss
Tablets
100 mg
Glytuss
Tablets
200 mg
GuiaCough CF
Liquid
12.5 mg
GuiaCough PE
Liquid
100 mg
Guiafenex LA
Tablets, extended release
600 mg
Guiatuss
Syrup
100 mg/5 mL
Humibid LA
Tablets, sustained release
600 mg
Humibid Sprinkle
Capsules, sustained release
300 mg
Hytuss
Tablets
100 mg
Hytuss 2x
Capsules
200 mg
Liquibid
Tablets, sustained release
600 mg
Monafed
Tablets, sustained release
600 mg
Muco-Fen-LA
Tablets, sustained release
600 mg
Mytussin
Syrup
100 mg/5 mL
Naldecon Senior EX
Liquid
200 mg/5 mL
Organidin NR
Tablets
200 mg
Liquid
100 mg/5 mL
Pneumomist
Tablets, sustained release
600 mg
Respa-GF
Tablets, sustained release
600 mg
Robitussin
Syrup
100 mg/5 mL
Scot-tussin Expectorant
Syrup
100 mg/5 mL
Sinumist-SR Capsulets
Tablets, sustained release
600 mg
Siltussin SA
Syrup
100 mg/5 mL
Touro Ex
Caplets, sustained release
600 mg
Tussin
Syrup
100 mg/5 mL
Tusibron
Syrup
100 mg/5 mL
Uni-tussin
Syrup
100 mg/5 mL
alminil Expectorant
Benylin E
Class: Expectorant

 Action May enhance output of respiratory tract fluid by reducing adhesiveness and surface tension, thus facilitating removal of viscous mucus and making nonproductive coughs more productive and less frequent. Efficacy not well documented.

 Indications Temporary relief of cough associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis, and asthma when these conditions are complicated by tenacious mucus or mucus plugs and congestion; effective for productive as well as nonproductive cough, particularly dry, nonproductive cough that tends to injure mucous membranes of the air passages.

 Contraindications Standard considerations.

 Route/Dosage

Immediate-release Adults and Children (at least 12 yr): PO 200 to 400 mg q 4 hr (max, 2.4 g/day).

Children (6 to 12 yr): PO 100 to 200 mg q4 hr (max, 1.2 g/day).

Children (2 to 6 yr): PO 50 to 100 mg q 4 hr (max, 600 mg/day).

Children (6 mo to under 2 yr): PO Individualize dose, 25 to 50 mg q 4 hr (max, 300 mg/day).

Sustained- or Extended-release Adults and children (at least 12 yr): PO 575 mg to 1.2 g q 12 hr (max, 2.4 g/day).

Children (6 to 12 yr): PO 575 to 600 mg q 12 hr (max, 1.2 g/day).

Children (2 to 6 yr): PO 275.5 to 300 mg q 12 hr (max, 600 mg/day).

 Interactions

None well documented.

 Lab Test Interferences May cause color interference with certain laboratory determinations of 5-hydroxyindoleacetic acid and vanillylmandelic acid. Discontinue use 48 hr before test.

 Adverse Reactions

CNS: Dizziness; headache. DERMATOLOGIC: Rash; urticaria. GI: Nausea; vomiting.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Persistent cough: May indicate serious condition. Notify physician, pharmacist, or nurse if cough persists for more than 1 wk, tends to recur or is accompanied by high fever, rash, or persistent headache.


PATIENT CARE CONSIDERATIONS


 Administration/Storage

 Assessment/Interventions

 Patient/Family Education

Books@Ovid
Copyright
© 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts